Awiqli
Stories
-
FDA approves first once-weekly insulin for type 2 diabetes in pediatric patients
Awiqli (insulin icodec-abae) is approved for children aged 10 years and older with type 2 diabetes mellitus. The drug is administered by subcutaneous injection once weekly and was approved after a priority review.